Announcements Trials
Browse Landscape

Status

Completed 21Terminated 6Withdrawn 2No longer available 2Unknown 1

Sponsor Class

INDUSTRY 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Multiple Myeloma 2Recurrence 1

Interventions

elotuzumab 4Lenalidomide 3Dexamethasone 3Bortezomib 3Panobinostat 2ulocuplumab 1talquetamab 1selinexor 1pomalidomide 1plerixafor 1fludarabine phosphate 1ceritinib 1carfilzomib 1Whole-Body Irradiation 1Tacrolimus 1Prednisone 1Mycophenolic Acid 1Melphalan 1Cytarabine 1Crizotinib 1Cord Blood Stem Cell Transplantation 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × Panobinostat × Plasma cell × Clear all
NCT02568943 2020-04-08

An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple Myeloma

Novartis

No longer available
Plasma cell

Multiple Myeloma, Recurrence

NCT02204553 2016-01-05

Expanded Treatment Prot of Panobinostat in Combo w/ Bortez and Dex in Pts w/ Relapsed and/or Refractory Multiple Myeloma

Novartis

No longer available
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡